These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 28393712)

  • 61. Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A).
    Crowder KM; Gunther JM; Jones TA; Hale BD; Zhang HZ; Peterson MR; Scheller RH; Chavkin C; Bajjalieh SM
    Proc Natl Acad Sci U S A; 1999 Dec; 96(26):15268-73. PubMed ID: 10611374
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Pharmacological Profile of the Novel Antiepileptic Drug Candidate Padsevonil: Interactions with Synaptic Vesicle 2 Proteins and the GABA
    Wood M; Daniels V; Provins L; Wolff C; Kaminski RM; Gillard M
    J Pharmacol Exp Ther; 2020 Jan; 372(1):1-10. PubMed ID: 31619465
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Psychopharmacology of anticonvulsants: levetiracetam as a synaptic vesicle protein modulator.
    Stahl SM
    J Clin Psychiatry; 2004 Sep; 65(9):1162-3. PubMed ID: 15367040
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Integration of postmortem amygdala expression profiling, GWAS, and functional cell culture assays: neuroticism-associated synaptic vesicle glycoprotein 2A (SV2A) gene is regulated by miR-133a and miR-218.
    Jurkiewicz M; Moser D; Koller A; Yu L; Chen EI; Bennett DA; Canli T
    Transl Psychiatry; 2020 Aug; 10(1):297. PubMed ID: 32839459
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Synaptic Vesicle Glycoprotein 2A: Features and Functions.
    Rossi R; Arjmand S; Bærentzen SL; Gjedde A; Landau AM
    Front Neurosci; 2022; 16():864514. PubMed ID: 35573314
    [TBL] [Abstract][Full Text] [Related]  

  • 66. SV2C is a synaptic vesicle protein with an unusually restricted localization: anatomy of a synaptic vesicle protein family.
    Janz R; Südhof TC
    Neuroscience; 1999; 94(4):1279-90. PubMed ID: 10625067
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Interaction of Approved Drugs with Synaptic Vesicle Protein 2A.
    Danish A; Namasivayam V; Schiedel AC; Müller CE
    Arch Pharm (Weinheim); 2017 Apr; 350(3-4):. PubMed ID: 28220535
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Expression pattern of synaptic vesicle protein 2 (SV2) isoforms in patients with temporal lobe epilepsy and hippocampal sclerosis.
    Crèvecoeur J; Kaminski RM; Rogister B; Foerch P; Vandenplas C; Neveux M; Mazzuferi M; Kroonen J; Poulet C; Martin D; Sadzot B; Rikir E; Klitgaard H; Moonen G; Deprez M
    Neuropathol Appl Neurobiol; 2014 Feb; 40(2):191-204. PubMed ID: 23617838
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Anxiety-like features and spatial memory problems as a consequence of hippocampal SV2A expression.
    Serrano ME; Bartholomé O; Van den Ackerveken P; Ferrara A; Rogister B; Plenevaux A; Tirelli E
    PLoS One; 2019; 14(6):e0217882. PubMed ID: 31166988
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A single dose of cocaine raises SV2A density in hippocampus of adolescent rats.
    Rossi R; Bærentzen SL; Thomsen MB; Real CC; Wegener G; Grassi-Oliveira R; Gjedde A; Landau AM
    Acta Neuropsychiatr; 2024 Apr; 36(2):109-117. PubMed ID: 36847240
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Modulation of the conformational state of the SV2A protein by an allosteric mechanism as evidenced by ligand binding assays.
    Daniels V; Wood M; Leclercq K; Kaminski RM; Gillard M
    Br J Pharmacol; 2013 Jul; 169(5):1091-101. PubMed ID: 23530581
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Physiologically based pharmacokinetic/pharmacodynamic animal-to-man prediction of therapeutic dose in a model of epilepsy.
    Brochot A; Zamacona M; Stockis A
    Basic Clin Pharmacol Toxicol; 2010 Mar; 106(3):256-62. PubMed ID: 20102365
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Identification of the antiepileptic racetam binding site in the synaptic vesicle protein 2A by molecular dynamics and docking simulations.
    Correa-Basurto J; Cuevas-Hernández RI; Phillips-Farfán BV; Martínez-Archundia M; Romo-Mancillas A; Ramírez-Salinas GL; Pérez-González ÓA; Trujillo-Ferrara J; Mendoza-Torreblanca JG
    Front Cell Neurosci; 2015; 9():125. PubMed ID: 25914622
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Phosphorylation of synaptic vesicle protein 2A at Thr84 by casein kinase 1 family kinases controls the specific retrieval of synaptotagmin-1.
    Zhang N; Gordon SL; Fritsch MJ; Esoof N; Campbell DG; Gourlay R; Velupillai S; Macartney T; Peggie M; van Aalten DM; Cousin MA; Alessi DR
    J Neurosci; 2015 Feb; 35(6):2492-507. PubMed ID: 25673844
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Solubilization and immunopurification of rat brain synaptic vesicle protein 2A with maintained binding properties.
    Lambeng N; Grossmann M; Chatelain P; Fuks B
    Neurosci Lett; 2006 May; 398(1-2):107-12. PubMed ID: 16434140
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A
    Calame DG; Herman I; Riviello JJ
    Epilepsy Behav Rep; 2021; 15():100425. PubMed ID: 33554103
    [No Abstract]   [Full Text] [Related]  

  • 77. Altered balance between excitatory and inhibitory inputs onto CA1 pyramidal neurons from SV2A-deficient but not SV2B-deficient mice.
    Venkatesan K; Alix P; Marquet A; Doupagne M; Niespodziany I; Rogister B; Seutin V
    J Neurosci Res; 2012 Dec; 90(12):2317-27. PubMed ID: 22847229
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Levetiracetam accelerates the onset of supply rate depression in synaptic vesicle trafficking.
    García-Pérez E; Mahfooz K; Covita J; Zandueta A; Wesseling JF
    Epilepsia; 2015 Apr; 56(4):535-45. PubMed ID: 25684406
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Biallelic variants in the synaptic vesicle glycoprotein 2 A are associated with epileptic encephalopathy.
    Al-Maawali A; Al-Murshedi F; Al-Futaisi A; Mansy A; Al-Habsi A; Girisha KM
    Eur J Hum Genet; 2024 Feb; 32(2):243-246. PubMed ID: 37985816
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Brivaracetam for the treatment of epilepsy.
    Schulze-Bonhage A
    Expert Opin Pharmacother; 2011 Aug; 12(12):1959-66. PubMed ID: 21682662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.